“MYC expression is negatively regulated by miR-34a, implying that the loss of miR-34a expression in DLBCL may further de-repress MYC and perpetuate the oncogenic consequences of MYC dysregulation” [51]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.